• HOME
  • SUPPORT
  • CONTACT US
  • LOGIN / REGISTER
LOGIN OR REGISTER
Course Library

Course Filtering Options

ALL COURSES
FEATURED
CURRICULA
ARCHIVED
  • By Course Topics
  • By Publish Date
  • By Course Title

CURRICULA COURSES BY TOPIC

Addiction Medicine

Emerging Challenges 2019 - ADHD

Emerging Challenges 2019 - ADHD Atlanta

LAUNCH DATE: 20-Apr-2018

EXPIRATION DATE: 20-Apr-2019

Emerging Challenges 2019 - ADHD Atlanta Simulcast

LAUNCH DATE: 20-Apr-2018

EXPIRATION DATE: 20-Apr-2019

Emerging Challenges 2019 - ADHD Baltimore

LAUNCH DATE: 20-Apr-2018

EXPIRATION DATE: 20-Apr-2019

Emerging Challenges 2019 - ADHD Birmingham

LAUNCH DATE: 20-Apr-2018

EXPIRATION DATE: 20-Apr-2019

Emerging Challenges 2019 - ADHD Miami

LAUNCH DATE: 20-Apr-2018

EXPIRATION DATE: 20-Apr-2019

Emerging Challenges 2019 - ADHD Birmingham Simulcast

LAUNCH DATE: 20-Apr-2018

EXPIRATION DATE: 20-Apr-2019

Emerging Challenges 2019 - ADHD Raleigh

LAUNCH DATE: 20-Apr-2018

EXPIRATION DATE: 20-Apr-2019

Emerging Challenges 2019 - ADHD St Louis

LAUNCH DATE: 20-Apr-2018

EXPIRATION DATE: 20-Apr-2019

Emerging Challenges 2019 - ADHD Tampa

LAUNCH DATE: 20-Apr-2018

EXPIRATION DATE: 20-Apr-2019

Emerging Challenges 2019 - ADHD Virtual Simulcast

LAUNCH DATE: 20-Apr-2018

EXPIRATION DATE: 20-Apr-2019

CREDITS

Non Accredited

Neurology

Developmental and Epileptic Encephalopathies: Enhancing Patient Outcomes through Personalized Care

The Impact of Non-seizure Symptoms in Patients with Developmental and Epileptic Encephalopathies

LAUNCH DATE: 30-Sep-2024

EXPIRATION DATE: 31-Dec-2025

The Anti-seizure Medication Landscape and Their Effect on Non-seizure Symptoms

LAUNCH DATE: 30-Sep-2024

EXPIRATION DATE: 30-Sep-2025

Collaborative Care with NSS (Non-Seizure Symptoms) in Mind

LAUNCH DATE: 30-Sep-2024

EXPIRATION DATE: 31-Dec-2025

CREDITS

AMA PRA Category 1 Credit(s)™

Oncology

ESMO 2023 - 2024 Congress Updates

Antibody Drug Conjugates (ADC) - United States

LAUNCH DATE: 11-Sep-2024

EXPIRATION DATE: 11-Sep-2025

Defining the therapeutic algorithm in patients with HR positive breast cancer - United States

LAUNCH DATE: 11-Sep-2024

EXPIRATION DATE: 11-Sep-2025

CREDITS

AMA PRA Category 1 Credit(s)™

ESMO 2023 - 2024 Congress Updates (France)

Antibody Drug Conjugates (ADC) - France

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

Defining the therapeutic algorithm in patients with HR positive breast cancer - France

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

CREDITS

European CME credits

ESMO 2023 - 2024 Congress Updates - Germany

Antibody Drug Conjugates (ADC) - Germany

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

Defining the therapeutic algorithm in patients with HR positive breast cancer - Germany

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

CREDITS

European CME credits

ESMO 2023 - 2024 Congress Updates - Italy

Antibody Drug Conjugates (ADC) - Italy

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

Defining the therapeutic algorithm in patients with HR positive breast cancer - Italy

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

CREDITS

European CME credits

ESMO 2023 - 2024 Congress Updates - Japan

Antibody Drug Conjugates (ADC) - Japan

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

Defining the therapeutic algorithm in patients with HR positive breast cancer - Japan

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

CREDITS

European CME credits

ESMO 2023 - 2024 Congress Updates - Spain

Antibody Drug Conjugates (ADC) - Spain

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

Defining the therapeutic algorithm in patients with HR positive breast cancer - Spain

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

CREDITS

European CME credits

Unlocking the Potential: Advancements in ADC Therapy for Metastatic Triple Negative and HER+/HER2- Breast Cancer Treatment

Advancements in ADC Therapy for Metastatic Triple Negative and HR+/HER2- Breast Cancer Treatment

LAUNCH DATE: 23-Dec-2024

EXPIRATION DATE: 23-Dec-2025

CREDITS

AMA PRA Category 1 Credit(s)™

Pulmonary Disease

The Emerging Role of Biologics in COPD Management

Module 1 - Overview of COPD and Optimal Standard-of-Care Therapy

LAUNCH DATE: 02-Dec-2024

EXPIRATION DATE: 02-Dec-2025

Module 2 - New Understanding of COPD Pathophysiology and Emerging Biologic Therapies

LAUNCH DATE: 02-Dec-2024

EXPIRATION DATE: 02-Dec-2025

CREDITS

AMA PRA Category 1 Credit(s)™

Weight Management

Understanding Obesity Management through the Lens of Cultural Humility

Understanding Obesity Management Through the Lens of Cultural Humility

LAUNCH DATE: 29-Jul-2024

EXPIRATION DATE: 28-Jul-2025

CREDITS

AMA PRA Category 1 Credit(s)™

  • Cookie Policy
Powered By RealCME © 2007-2025 HealthCourse, Inc. All rights reserved.
  • Support
  • Privacy Policy
  • Terms of Service
  • Contact Us
Error
Coming Soon

Coming Soon

Schedule an event with a Standardized Patient
×